Not applicableStudy completedNCT03941184What this trial is testingSpontaneous Coronary Artery Dissection (SCAD) and AutoimmunityWho this might be right forSCADAddison DiseaseAnkylosing Spondylitis+26 more Mayo Clinic 114
Not applicableEnded earlyNCT07449234What this trial is testingGuselkumab After Switching From Ustekinumab in Participants With Moderate to Severe PsoriasisWho this might be right forPsoriasis Janssen-Cilag Ltd. 9
Post-approval studies (Phase 4)UnknownNCT01088165What this trial is testingThe Influence of Adalimumab on Cardiovascular and Metabolic Risk in PsoriasisWho this might be right forPsoriasisCardiovascular DiseasesDiabetes Mellitus, Type 2 Medical University of Vienna 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT06875934What this trial is testingA Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis Guangdong Hengrui Pharmaceutical Co., Ltd 145
Testing effectiveness (Phase 2)UnknownNCT05604898What this trial is testingRecombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPsoriasis Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 139
Testing effectiveness (Phase 2)Looking for participantsNCT06231381What this trial is testingEfficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)Who this might be right forGeneralized Pustular Psoriasis (GPP) Shanghai Huaota Biopharmaceutical Co., Ltd. 33
Early research (Phase 1)WithdrawnNCT01260844What this trial is testingOpen Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.Who this might be right forModerate to Severe Plaque Psoriasis Abbott 12
Large-scale testing (Phase 3)Study completedNCT06588738What this trial is testingA Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001Who this might be right forPlaque Psoriasis Alumis Inc 862
Testing effectiveness (Phase 2)Study completedNCT02931838What this trial is testingStudy to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe PsoriasisWho this might be right forPsoriasis Bristol-Myers Squibb 268
Large-scale testing (Phase 3)Looking for participantsNCT07265284What this trial is testingEvaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 104
Testing effectiveness (Phase 2)Study completedNCT03010527What this trial is testingEvaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis UCB Biopharma SRL 217
Early research (Phase 1)Study completedNCT02156466What this trial is testingMultiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis SubjectsWho this might be right forPsoriasis Merck KGaA, Darmstadt, Germany 41
Not applicableStudy completedNCT00678470What this trial is testingOpen Label Study of Alefacept Injections to Patients With Moderate to Severe PsoriasisWho this might be right forModerate to Severe Psoriasis University of California, San Francisco 18
Early research (Phase 1)Ended earlyNCT01948271What this trial is testingEfficacy Study of Trichuris Suis Ova to Treat Chronic Plaque PsoriasisWho this might be right forPsoriasis Tufts Medical Center 3
Large-scale testing (Phase 3)Study completedNCT01412944What this trial is testingEfficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type PsoriasisWho this might be right forPlaque-type Psoriasis Novartis Pharmaceuticals 43
Not applicableLooking for participantsNCT07039110What this trial is testingStudy to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis AbbVie 700
Large-scale testing (Phase 3)Study completedNCT06011733What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque PsoriasisWho this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis UCB Biopharma SRL 133
Testing effectiveness (Phase 2)Study completedNCT01230138What this trial is testingPivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Forward-Pharma GmbH 252
Large-scale testing (Phase 3)Study completedNCT03255382What this trial is testingAssess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic TherapyWho this might be right forPsoriasis AbbVie 120
Testing effectiveness (Phase 2)Study completedNCT00852670What this trial is testingACT-128800 in PsoriasisWho this might be right forPlaque Psoriasis Actelion 66